Chemical Structure : Alnuctamab
Catalog No.: PC-38851Not For Human Use, Lab Use Only.
Alnuctamab (CC-93269) is a T-cell redirecting bispecific antibody (BiTE) targeting BCMA for the treatment of multiple myeloma.
Packing | Price | Stock | Quantity |
---|---|---|---|
1 mg | Get quote | ||
5 mg | Get quote | ||
10 mg | Get quote | ||
25 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Alnuctamab (CC-93269) is a T-cell redirecting bispecific antibody (BiTE) targeting BCMA (TNFRSF17) and CD3ε for the treatment of multiple myeloma, binds bivalently to BCMA and monovalently to CD3ε in a 2+1 format.
Isotype: G1-kappa/lambda with domain crossover
Anti-[human TNFRSF17 (TNF receptor superfamily member 17, tumor necrosis factor receptor superfamily, member 17, B cell maturation antigen, BCMA, BCM, TNFRSF13A, CD269)] and anti-[human CD3E (CD3 epsilon, Leu-4)], monoclonal antibody, bispecific, trivalent.
M.Wt | ||
Formula | ||
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright